Influential scientific researchers in the ME/CFS community will come together this Saturday, Aug. 12 for a one-day community symposium focused on the molecular basis of ME/CFS at Stanford University Palo Alto, California.
The symposium will be held from 9 a.m. to 5 p.m. PST, (California time). The event follows a two-day meeting of the the world-renowned scientists sponsored by the Open Medicine Foundation.
“To date we have been able to develop a potential diagnostic and treatment screening assay using our new nanofabricated device on a few patients and healthy controls,” wrote Ronald W. Davis, PhD in a welcome letter to the symposium. Davis is director of the Stanford Genome Technology Center and director of the Chronic Fatigue Syndrome Research Center at Stanford University. “We have also generated a large amount of molecular data on a few patients, which has pointed to pathways that should help us understand the disease. Our collaborative team meeting will allow for in-depth scientific discussion of ME/CFS research results, and for strategizing on the best way forward for the scientific community.
“At the Community Symposium, the scientists will update patients and any interested members of the public on our progress towards understanding the molecular basis of ME/CFS and our plans for the future.
Only together can we solve this incredibly complex and horrific disease.”